Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Cancer

Explore clinical trials studying Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

1,159 public trials 213 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Cancer trial results

Completed

Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

NCT00040807

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Medical Center of Aurora - South Campus Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 43 locations
View Trial Details
Completed

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

NCT00002922

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 24 locations
View Trial Details
Completed

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

NCT00002632

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Mouth Diseases, +6 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University Hospital - Atlanta Atlanta, Georgia, United States
View all 29 locations
View Trial Details
Completed

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

NCT00003206

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Nasopharyngeal Diseases, +8 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University Hospital - Atlanta Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

NCT00014118

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Watson Clinic, LLC Lakeland, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
View all 47 locations
View Trial Details
Completed

Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

NCT00054561

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
View all 89 locations
View Trial Details

Related conditions